Skip to main content
Share

World's leading clinical conference on bone, joint and muscle health

Programme

Go to Sponsored Sessions

Saturday April 13th - GMT Time zone

08:00 - 09:00
Non-Sponsored Symposia
08:00
MR3
Osteoporosis and atherosclerotic heart disease Chairperson : Peter R. Ebeling
  • Vascular-Bone Nexus: A narrative review of the Evidence from epidemiological Studies and randomized controlled Trials Joshua Lewis
  • A model for Bone as the Source of Calcification in Atherosclerotic Heart Disease Gordon Klein
08:00
MR4
Insights into ageing: lessons from the senior and sarcophage cohorts on frailty and sarcopenia Chairperson : Olivier Bruyère
  • SENIOR contributions to frailty, nutrition and physical activity Fanny Buckinx
  • SarcoPhAge contributions to sarcopenia, malnutrition and quality of life Charlotte Beaudart
  • The SENIOR and SarcoPhAge cohorts to study COVID and long-term mortality Céline Demonceau
  • Conclusion and questions Olivier Bruyère
08:00
MR5
Capture the Fracture® : global perspectives and experience Chairpersons : Nicholas Harvey & Maria Luisa Brandi
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – Asia-Pacific Manju Chandran
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – Europe Maria Luisa Brandi
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – North America Famida Jiwa
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – Latin America Patricia Clark
08:00
MR6
The fatal attraction of cancer and bone Chairpersons : Janet Brown & Peyman Hadji
  • Treatment induced Osteoporosis in women with breast cancer Peyman Hadji
  • Treatment induced Osteoporosis in men with prostate cancer Janet Brown
  • Current guideline dependent treatment of bone metastasis Cyrille Confavreux
08:00
MR7
Sarcopenia state-of-the-art: components, definitions and global impact Chairpersons : Elaine M. Dennison & Elizabeth M. Curtis
  • Sarcopenia components and definitions: prevalence, agreement and predictive capacity regarding mortality Leo D. Westbury
  • Sarcopenia components and definitions as predictors of fracture risk Nicholas Harvey
  • Prevalence and burden of sarcopenia in sub-Saharan Africa Kate A. Ward
08:00
MR8
Assessment of risk of falls and fracture in older women: project in primary care in women’s health Chairperson : Bruno Muzzi Camargos
  • Construction of a project to assess the risk of falls based on women’s musculoskeletal physiology Oslei de Matos
  • Development of a fall risk assessment protocol based on musculoskeletal and comprehensive assessment: protocols and main results Brenda Lenardt
08:00 - 09:00
MR2
DVO-ESCEO Joint Symposium The DVO Concept to provide Care for Patients with Osteoporosis and Bone Diseases in German speaking countries Chairpersons : John A. Kanis & Ralf Schmidmaier
  • The new DVO guidelines for osteoporosis 2023 – a paradigm change for the german speaking countries Friederike Thomasius
  • Disease Management Program Osteoporosis - a politically decided structured care program for Germany Andreas Kurth
  • A new case finding algorithm according to fracture risk Claus Glüer
  • Medical education in Osteology care: from basic research to clinical competence certification Ralf Schmidmaier
09:00 - 10:30
Auditorium A
Scientific Session IV Chairpersons : Bess Dawson-Hughes & Olivier Bruyère
09:00
Auditorium A
Plenary Lecture 5 Bone resorption inhibitors beyond the skeleton Bo Abrahamsen
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
09:30
Auditorium A
Oral communication selected from abstracts OC19: DXA-DERIVED HIP SHAPE IS PREDICTIVE OF HIP FRACTURE: A LONGITUDINAL STUDY FROM UK BIOBANK Presenting author: S. Scott Authors: A. Hashmi, R. Ebsim, F. R. Saunders, J. S. Gregory, R. M. Aspden, C. Lindner, T. Cootes, N. Harvey, J. H. Tobias, B. G. Faber and R. Beynon
09:40
Auditorium A
Oral communication selected from abstracts OC20: GREATER THIGH MUSCLE MASS MEASURED BY MRI IS ASSOCIATED WITH REDUCED INCIDENT FRACTURE RISK IN WOMEN, BUT NOT MEN: FINDINGS FROM THE UK BIOBANK Presenting author: E. M. Curtis Authors: S. D'Angelo, R. J. Moon, J. Paccou, N. R. Fuggle, E. M. Dennison, C. Cooper, K. A. Ward and N. Harvey
09:50
Auditorium A
Oral communication selected from abstracts OC21: HIP GEOMETRY AND FRACTURE AMONG IRISH MEN AND WOMEN: THE DXA HIP PROJECT Presenting author: M. Ebrahimiarjestan Authors: E. E., A. Brennan, L. Yang, T. Wang, C. Silke, M. O'Sullivan, M. Dempsey, M. Yu, J. Carey, G. O'Malley, A. Mcpartland and B. Rooney
10:00
Auditorium A
Oral communication selected from abstracts OC22: COST-EFFECTIVENESS OF RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS) FOR THE DIAGNOSIS OF OSTEOPOROSIS IN THE UNITED STATES Presenting author: M. Hiligsmann Author: J.-Y. Reginster
10:10
Auditorium A
Oral communication selected from abstracts OC23: EXTERNAL VALIDATION OF AI-DRIVEN BONE FRAGILITY DETECTION IN RADIOGRAPHS FROM MULTINATIONAL COHORTS Presenting author: M. De Gruttola Authors: G. Gatineau, G. Nguyen, K. Hind, M. Kužma, J. Payer, G. Guglielmi, A. Fahrleitner-Pammer and D. Hans
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award René Rizzoli
10:30 - 12:10
Auditorium A
Scientific Session V Chairpersons : Charlotte Beaudart & Eugene V. McCloskey
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award Eugene V. McCloskey
10:40
Auditorium A
Plenary Lecture 6 Management of osteoporosis in multi-ethnic societies Manju Chandran
Have a sneak peek
11:10
Auditorium A
Oral communications selected from abstracts
11:10
Auditorium A
Oral communication selected from abstracts OC24: VITAMIN D METABOLITE RATIO (VMR) OFFERS THE BEST APPROACH TO EVALUATE FUNCTIONAL VITAMIN D DEFICIENCY: RESULTS OF THE SARCOPHAGE STUDY Presenting author: E. Cavalier Authors: A. Ladang, A.-S. Gendebien, S. Kovacs, C. Demonceau, C. Beaudart, C. Le Goff, J.-Y. Reginster and O. Bruyère
11:20
Auditorium A
Oral communication selected from abstracts OC25: CALCITRIOL SUPPLEMENTATION AFTER KIDNEY TRANSPLANTATION: RESULTS OF A DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL Presenting author: T. Nickolas Authors: P. Khairallah, S. Sammons, S. Agarwal, N. Cortez, M. Fusaro, M. Plebani, M. Zaninotto and C. Cosma
11:30
Auditorium A
Oral communication selected from abstracts OC26: FRACTURE LIAISON SERVICES AND SUBSEQUENT FRACTURE RISK: A MULTICENTER, PRAGMATIC, STEPPED-WEDGE CLUSTER-RANDOMIZED CONTROLLED TRIAL Presenting author: F. Frihagen Authors: C. Andreasen, C. Dahl, T. T. Borgen, T. Basso, J. E. Gjertsen, W. Figved, T. Wisløff, G. Hagen, E. M. Apalset, J. M. Stutzer, I. Lund, A. K. Hansen, F. I. Nissen, R. M. Joakimsen, U. Syversen, E. F. Eriksen, L. Nordsletten, T. K. Omsland, A. Bjørnerem and L. B. Solberg
11:40
Auditorium A
Oral communication selected from abstracts OC27: PROTON PUMP INHIBITORS ASSOCIATED WITH INCREASED BONE TURNOVER MARKERS: RESULTS OF A LARGE OBSERVATIONAL COHORT STUDY Presenting author: D. Fitzpatrick Authors: R. Lannon, E. Laird, M. Ward, L. Hoey, C. F. Hughes, J. J. Strain, C. Cunningham, H. Mc Nulty and K. Mc Carroll
11:50
Auditorium A
Oral communication selected from abstracts OC28: DISCONTINUATION OF BISPHOSPHONATES IN OLDER PEOPLE WITH COMPLEX HEALTH NEEDS: SELF-CONTROLLED CASE SERIES TO ASSESS FRACTURE RISK Presenting author: A. M. Jödicke Authors: D. Prieto-Alhambra, F. Dernie, A. Delmestri, T. Rathod-Mistry and E. H. Tan
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Critical role of exercise in post fracture management Olivier Bruyère & Daniel Pinto
14:00
MR7
Transgender medicine: key challenges in the management of musculoskeletal disease Jean-Marc Kaufman
14:00
MR8
Achieving optimal musculoskeletal health in HIV Emmanuel Biver
14:00 - 15:00
Podium
Oral presentations of selected posters Chairperson : K. A. Ward
14:00
Podium
P1091 GUT MICROBIOTA AND SHORT-CHAIN FATTY ACID SIGNATURES IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS：A RETROSPECTIVE STUDY Presenting author: P. Sun Authors: S. Li, Y. Zhang, C. Ma and Q. Dong
14:06
Podium
P1122 EXPECTED LOSS OF PRODUCTIVITY FOLLOWING FRAGILITY FRACTURES IN PATIENTS OF WORKING AGE Presenting author: R. Pinedo-Villanueva Authors: J. Griffin, L. Wiggins, N. Nicola, C. Jones and K. M. Javaid
14:12
Podium
P228 THE ICARE FEASIBILITY STUDY: AN INTEGRATED COLLECTION OF EDUCATION MODULES FOR FALL AND FRACTURE PREVENTION FOR HEALTHCARE PROVIDERS IN LONG TERM CARE Presenting author: A. Papaioannou Authors: G. Ioannidis, L. Hillier, J. D. Adachi, A. Costa, G. Heckman, J. Hirdes, J. Holroyd-Leduc, S. Jaglal, S. Kaasalainen, A. Lau, C. McArthur, L. Kane, S. Marr, S. Straus, J.-E. Tarride, L. Thabane, M. Abbas and I. Rodrigues
14:18
Podium
P754 ANXIETY AND DEPRESSION ARE ASSOCIATED WITH POOR HEALTH BEHAVIOURS AND INCIDENT FRACTURE AMONG WOMEN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: L. D. Westbury Authors: G. Bevilacqua, C. Cooper and E. M. Dennison
14:24
Podium
P863 BONE MINERAL DENSITY POST-TREATMENT FOLLOW-UP IN WOMEN WITH ENDOMETRIOSIS TREATED WITH RELUGOLIX COMBINATION THERAPY: SPIRIT PROGRAMME Presenting author: M. McClung Authors: N. Johnson, S. Ferrari, J. S. Perry, Y. Zhong and R. B. Wagman
14:30
Podium
P679 COMPARATIVE ANALYSIS OF TERIPARATIDE AND ROMOSOZUMAB IN PREVENTING SYMPTOMATIC SUBSEQUENT VERTEBRAL COMPRESSION FRACTURE AFTER CEMENTING Presenting author: J.-H. Jiann-Her Authors: W.-H. Kao, Y.-H. Chiang, W.-C. Lo and M.-H. Wu
14:36
Podium
P1136 STANDARD X-RAY IMAGES MAY POTENTIALLY BE USED TO QUANTIFY BONE DISORGANIZATION AND IDENTIFY PATIENTS WITH HYPOPHOSPHATASIA Presenting author: R. Zebaze Authors: C. Shore-Lorenti, Z. Simon, K. Djopseu, T. Makebeh, F. Milat and P. R. Ebeling
14:42
Podium
P280 ASSESSMENT OF ADHERENCE TO ANTI-OSTEOPOROTIC MEDICATION (AOM) TREATMENT IN THE RISK-STRATIFIED OSTEOPOROSIS STRATEGY EVALUATION (ROSE) SCREENING PROGRAMME: A TEN-YEAR FOLLOW-UP STUDY Presenting author: B. Abrahamsen Authors: T. G. Petersen, K. H. Rubin, K. M. Javaid, A. P. Hermann and K. Akesson
14:48
Podium
P1013 THE EFFECT OF EIGHT MONTHS OF BALLISTIC AND CONVENTIONAL RESISTANCE EXERCISE TRAINING ON BONE STRENGTH IN POSTMENOPAUSAL WOMEN: THE REPROOF STUDY Presenting author: O. Caliskan Authors: E. A. Marques, J. P. Folland and K. Brooke-Wavell
14:54
Podium
P142 CALCIUM (CA) ISOTOPE COMPOSITION IN SERUM AND URINE FOR THE ASSESSMENT OF BONE CALCIUM BALANCE (BCAB) – RESULTS FROM A POST-MARKET SURVEILLANCE CLINICAL FOLLOW-UP STUDY ON 2409 PARTICIPANTS Presenting author: A. Eisenhauer Authors: A. Heuser, J. Oehme, M. Lutz and M. Müller
14:00 - 15:00
Poster Area
Poster Viewing Session II
14:00 - 15:00
Auditorium B
Sponsored Educational Lecture

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
MR1
EUGMS-ESCEO Joint Symposium Improving fragility fracture care: a multidisciplinary perspective Chairperson : Tahir Masud
  • Optimizing fracture prevention and rehabilitation in frail older persons: the exercise & physiotherapy perspective Dawn Skelton
  • Optimizing fracture prevention and rehabilitation in frail older persons: the nursing & care home perspective Ellen Vlaeyen
14:00 - 15:00
MR2
OARSI-ESCEO Joint Symposium Managing Bone and Joint Diseases in Older Aged: Epidemiology and Lessons for the Clinic Chairpersons : Gun-il Im & Elizabeth M. Curtis
  • Immunometabolic Alterations Linking Diabetes Osteoarthritis and Osteoporosis Ali Mobasheri
  • Impact of Osteoporosis and Osteoarthritis as Comorbidities in the Aging Population Elaine M. Dennison
14:00 - 15:00
MR5
ESCEO Symposium ESCEO Working Group on “REMS in the diagnosis and management of osteoporosis: State of the art” Chairpersons : Radmila Matijevic & Andreas Kurth
  • REMS : How does it work and what do we measure? Adolfo Diez-Perez
  • What is the contribution of REMS to the management of post-menopausal osteoporosis? Nicholas Harvey
  • What is the contribution of REMS in the management of musculoskeletal health, outside of post-menopausal osteoporosis? Maria Luisa Brandi
  • Discussion All
15:00 - 17:00
Auditorium A
Scientific Session VI Chairpersons : Jean-Yves Reginster & Radmila Matijevic
15:00
Auditorium A
Plenary Lecture 7 How should we define sarcopenia? Past, present and future perspectives Alfonso J. Cruz-Jentoft
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
15:30
Auditorium A
Oral communication selected from abstracts OC29: GLOBAL BALANCE OF THE SPINE, AN INDEPENDENT CONTRIBUTOR TO PHYSICAL IMPAIRMENTS AND PREDICTOR OF INCIDENT FALLS IN OLDER ADULTS: THE SAFE 3-YEAR LONGITUDINAL COHORT STUDY Presenting author: A. Trombetti Authors: M. Hars, A. Faundez, M.-J. Begin, M. Terrien Ferey, J. Fechtenbaum, K. Briot, C. Roux, F. Herrmann, C. Graf, S. Ferrari, S. Genevay and S. Boudabbous
15:40
Auditorium A
Oral communication selected from abstracts OC30: A NOVEL DRUG COMBINATION WITH THERAPEUTIC POTENTIAL FOR SARCOPENIA Presenting author: A. Beliën Authors: E. Mercken, J. Frickel, S. Huettner, J.-Y. Reginster, C. Tezze and M. Sandri
15:50
Auditorium A
Oral communication selected from abstracts OC31: IMMINENT FRACTURE RISK AND MORTALITY DIFFER BY INDEX FRACTURE SITE AND BONE MINERAL DENSITY Presenting author: K. M. Javaid Authors: R. Pinedo-Villanueva and W. D. Leslie
16:00
Auditorium A
Oral communication selected from abstracts OC32: EFFECT OF FRAXPLUS ADJUSTMENTS ON FRACTURE RISK RECLASSIFICATION IN OLDER SWEDISH WOMEN – RESULTS FROM THE SUPERB-STUDY Presenting author: M. Zoulakis Authors: H. Johansson, N. Harvey, K. F. Axelsson, H. Litsne, L. Johansson, E. Liu, M. Schini, L. Vandenput, E. V. McCloskey, J. A. Kanis and M. Lorentzon
16:10
Auditorium A
Oral communication selected from abstracts OC33: SMOKING HISTORY AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX® RISK ASSESSMENT TOOL Presenting author: H. Johansson Authors: M. Schini, N. Harvey, M. Lorentzon, E. Liu, L. Vandenput, J. A. Kanis, E. V. McCloskey and The Frax Meta-Analysis Cohort
16:20
Auditorium A
Oral communication selected from abstracts OC34: QUANTITATIVE MOTION ARTEFACT GRADING IN HR-PQCT CLINICAL IMAGING: AN ALGORITHMIC APPROACH Presenting author: T. Cox Authors: S. Mahmoodi, L. D. Westbury, N. R. Fuggle, S. Lu and N. Harvey
16:30
Auditorium A
Plenary Lecture 8 Sarcopenia management: muscle-targeted interventions for healthy ageing Antonio Cherubini
Have a sneak peek
15:00 - 16:45
MR5
Committee of Scientific Advisors Special Session IOF CSA Special Session 2024: Hip fracture to marrow adiposity and hypophosphatasia: advances in understanding skeletal disease Chairpersons : Nicholas Harvey & Eugene V. McCloskey
  • Optimisation of hip fracture services: lessons from the REDUCE Study Celia L. Gregson
  • Bone marrow adiposity: new understanding in osteoporosis pathogenesis Julien Paccou
  • State-of-the-art in hypophosphatasia: recent recommendations from international working groups Maria Luisa Brandi
17:00 - 18:00
Non-Sponsored Symposia
17:00
MR1
How to write a good review article Chairpersons : Olivier Bruyère & Nasser Al-Daghri
  • How to write a narrative review Shaun Sabico
  • How to write a systematic review and meta-analysis Germain Honvo
  • How to write an umbrella review Nicola Veronese
17:00
MR2
Understanding exercise for osteoporosis Chairperson : Belinda R. Beck
  • The principles of osteogenic loading Katherine Brooke-Wavell
  • Translation of osteogenic principles into effective exercise prescription Belinda R. Beck
17:00
MR3
Information and knowledge impact risk perception and awareness of musculoskeletal diseases – a path toward effectiveness Chairperson : Fatjona Kamberi
  • Knowledge, risk perception, and impact on engagement in the prevention of musculoskeletal diseases – the focus group on Vitamin D Fatjona Kamberi
  • Self-education in chronic patients with musculoskeletal conditions Doreada Mio
  • Physiotherapy in Osteoporosis. Practice behaviors and Physiotherapists’ perceptions in Albania Enkeleda Sinaj
  • Evaluation of Knowledge on the Impact of Vitamin D on Osteoarthritis Glodiana Sinanaj
17:00
MR4
Primary hyperparathyroidism as a cause of osteoporosis. Diagnosis and management Chairpersons : Panagiotis Athanassiou & Ifigenia Kostoglou-Athanassiou
  • Primary hyperparathyroidism. Etiology and clinical manifestations Ifigenia Kostoglou-Athanassiou
  • Primary hyperparathyroidism and psychological implications Yannis Athanassiou
  • Primary hyperparathyroidism and muscular effects Lambros Athanassiou
  • Primary hyperparathyroidism and osteoporosis. The role of exercise Yannis Dionyssiotis
  • Primary hyperparathyroidism and osteoporosis. Management Panagiotis Athanassiou
17:00
MR5
Osteoporosis treatment beyond 10 years Chairperson : Bruno Muzzi Camargos
  • Long-term treatment of Osteoporosis: What’s up on 10-years after Geraldine Altamar Canales
  • Discontinuation of Anti-Osteoporosis Treatments: Should we do it, when and how Adriana Medina-Orjuela
  • Recommendations for Osteoporosis treatment beyond 10 years Andrès Felipe Coy Barrera
17:00
MR6
Bone health and vitamin D metabolism in chronic rheumatic diseases. Fibromyalgia and bone. Chairpersons : Willem Lems & Osvaldo Daniel Messina
  • Chronic arthritides and Bone Hennie G. Raterman
  • Vitamin D in patients with inflammatory rheumatic diseases Willem Lems
  • Fibromyalgia and bone Osvaldo Daniel Messina
17:00
MR7
How to optimize bone health in athletes? Chairperson : Sansin Tüzün
  • Scope of the Problem: Beyond the Female Athlete Triad Sansin Tüzün
  • Assessment of Bone Strength in Athletes John Carey
  • How can REMS be helpful to assess bone in Sports Medicine? Radmila Matijevic
  • How to Manage Bone Loss in Athletes? Rana Terlemez
17:00
MR8
Platelet-rich plasma in musculoskeletal pathologies Chairperson : Jean-François Kaux
  • Qualitative aspects of platelet-rich plasma injections Jean-François Kaux
  • Nerve anaesthesia for painful platelet-rich plasma injection Loïc Chimot
  • Post-procedure after platelet-rich plasma injection for a tendinopathy Martin Lamontagne